Trial
NCT02876211
Paricalcitol Improves Anemia of Inflammation
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Hospital Son Espases
Collaborators
—
Condition
Anemia
Intervention
Paricalcitol
Why stopped
Difficult inclusion of patients diagnosed with renal anemia in chronic hemodialysis patients without hyperparathyroidism.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-09